Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

| More on:

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • BHP Group's shares are rated overweight by Morgan Stanley, citing attractive valuations and favorable commodity outlooks, particularly for iron ore and copper.
  • Mesoblast retains a speculative buy rating from Bell Potter, bolstered by a new J-Code in the US for Ryoncil, which enhances billing and reimbursement processes.
  • Web Travel Group is seen as undervalued by Macquarie, highlighting its strong trading update and confidence in reaching a $10 billion transaction target by FY 2030.

Many of Australia's top brokers have been busy adjusting their financial models and recommendations again. This has led to the release of a number of broker notes this week.

Three ASX shares that brokers have named as buys this week are listed below. Here's why their analysts are feeling bullish on them right now:

BHP Group Ltd (ASX: BHP)

According to a note out of Morgan Stanley, its analysts have retained their overweight rating on this mining giant's shares with an improved price target of $48.00. The broker believes that ASX mining shares are trading on attractive valuations compared to industrials. And with the iron ore price historically performing well during a period of US dollar weakness, it feels this bodes well for BHP. In addition, it feels that copper has a bright outlook, which is also good news for the Big Australian. The BHP share price is trading at $41.93 on Wednesday.

Mesoblast Ltd (ASX: MSB)

A note out of Bell Potter reveals that its analysts have retained their speculative buy rating on this biotechnology company's shares with an improved price target of $4.00. This follows news that the CMS in the US has announced a specific J-Code for Ryoncil for billing and reimbursement from 1 October. Bell Potter highlights that the new permanent J-Code provides a standardised, clear, permanent, and specific billing pathway for Ryoncil by Medicaid, facilitating reimbursement and broader patient access. It feels that this means the December quarter is now shaping up as the breakout period. It also feels that its quarterly cash flow will show a large reduction in cash burn as cash inflows from product sales of Ryoncil commence. The Mesoblast share price is fetching $2.97 at the time of writing.

Web Travel Group Ltd (ASX: WEB)

Analysts at Macquarie have retained their outperform rating on this travel technology company's shares with an improved price target of $6.98. According to the note, Web Travel delivered a trading update slightly ahead of expectations. In light of this, the broker remains very positive on its outlook and is increasingly confident it will reach its $10 billion FY 2030 total transaction value target. And with UEBITDA margin visibility improving, the broker thinks its shares are cheap at current levels. In fact, Macquarie highlights that its shares are trading materially below its post-pandemic average multiples. It feels this is unjustified and represents a buying opportunity. The Web Travel share price is trading at $4.21 this afternoon.

Motley Fool contributor James Mickleboro has positions in Web Travel Group Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended BHP Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A young boy points and smiles as he eats fried chicken.
Broker Notes

Down 22% this year, does Macquarie rate Inghams shares a buy?

Is it time to buy low on this struggling stock?

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Broker Notes

Buy, hold, sell: Breville, CBA, Ramelius shares

Are analysts bullish or bearish on these names?

Read more »

Three cows jumping over a field of grass
Broker Notes

Why Macquarie expects this dividend paying ASX 300 stock to leap 19%

Macquarie forecasts a strong year ahead for this ASX 300 dividend stock.

Read more »

A group of business people in a board room hear the latest company report.
Broker Notes

What does Macquarie think QBE shares are worth?

Are QBE shares a buy, hold or sell according to Macquarie?

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

View of a business man's hand passing a $100 note to another with a bank in the background.
Bank Shares

Where to from here for Bendigo and Adelaide Bank shares?

Bendigo and Adelaide Bank shares are out of favour with Macquarie after a "weak" start to the year.

Read more »

Man ecstatic after reading good news.
Broker Notes

Macquarie tips 20% return for this ASX 200 stock

The broker is bullish on this stock. But why?

Read more »

Image of young successful engineer, with blueprints, notepad and digital tablet, observing the project implementation on construction site and in mine.
Broker Notes

Broker tips 90% upside for this ASX materials stock!

This materials stock is on the rise.

Read more »